What is the ticker symbol for Tenaya Therapeutics?

Tenaya Therapeutics trades under the ticker TNYA on NASDAQ.

What sector does Tenaya Therapeutics operate in?

Tenaya Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TNYA in a portfolio?

PortView shows TNYA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Tenaya Therapeutics (TNYA) Stock Analysis

NASDAQHealthcareBiotechnology

$0.69+1.08%

1-year price historyRange $0.55 – $2.10

52-week range$0.69

$0.53$2.35

What Tenaya Therapeutics does

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Key metrics

Market cap

$150.34M

P/E (TTM)

-1.31

EPS (TTM)

$-0.53

Beta

2.79

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$0.76

200-day avg

$0.81

52-week high

$2.35

52-week low

$0.53

CEO

Faraz Ali

ETFs linked to TNYA

Broad-market and Healthcare sector ETFs an investor holding Tenaya Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TNYA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TNYA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Tenaya Therapeutics?: Tenaya Therapeutics trades under the ticker TNYA on NASDAQ.
Which exchange is TNYA listed on?: TNYA is listed on NASDAQ.
What sector does Tenaya Therapeutics operate in?: Tenaya Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TNYA in a portfolio?: PortView shows TNYA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.